ClinicalTrials.Veeva

Menu
V

Vance Thompson Vision | Sioux Falls, SD

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MELT-300
Tetracaine
Ripasudil
K-321

Parent organization

This site is a part of Vance Thompson Vision

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 13 total trials

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

The goal of this clinical trial is to learn if MELT-300 works on procedural sedation in adult participants undergoing cataract extraction with lens r...

Enrolling
Cataract
Drug: MELT-300 sublingual tablet
Drug: Placebo sublingual tablet

Prospective, multicenter, bilateral, interventional, controlled, masked (sponsor, subjects, and evaluators), randomized clinical trial.

Enrolling
Cataracts
Device: Test IOL Model DEN00V
Device: Control IOL Model DCB00

Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucom...

Enrolling
Open-Angle Glaucoma
Device: XEN45 (Glaucoma Gel Stent)

This study will enroll subjects with stage 2 or 3 neurotrophic keratitis. Subjects will be randomized in a 1:1 ratio to the CSB-001 investigational t...

Active, not recruiting
Neurotrophic Keratitis
Biological: CSB-001 Ophthalmic Solution 0.1%
Biological: Vehicle Control

This study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 site...

Enrolling
Refractive Error
Device: iDesign Refractive Studio with STAR S4 IR® Excimer laser System

Trial sponsors

V
Johnson & Johnson (J&J) logo
AbbVie logo
A
Alcon logo
C
Kowa logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems